Organoleptic Agents occupy a significant market segment in the field of pharmaceutical excipients. These agents include a variety of additives used to colour, taste, sweeten, and texturize recipes. EVALUATION OF ORGANOLEPTIC Organoleptic (lit. "impression on the organs") relates to sensory evaluation and encompasses the macroscopic look of the drug, its odour and taste, and, on rare occasions, the sound or snap of its fracture, as well as the drug's feel to touch. Organoleptic agents occupy a significant market segment in the field of pharmaceutical excipients. These agents include a variety of additives used to colour, taste, sweeten, and texturize recipes. These agents have come to play an important role in medicines and cosmetics due to their capacity to promote patient compliance by improving the elegance and aesthetics of a formulation. However, before using them, it is critical to assess their physical and chemical properties, as organoleptic agents, like active pharmaceutical ingredients (APIs), are subject to physical and chemical instability, which leads to deterioration. API-organoleptic drug interaction, exposure to light, air, and oxygen, and changes in pH and temperature can all cause these instabilities. These organoleptic agent instabilities are of great concern because they influence API and formulation stability, potentially leading to API degradation or the manifestation of toxicity. As a result, it is necessary to examine and review the physicochemical qualities of organoleptic agents prior to their application.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand